TPMT and systemic lupus erythematosus: From these 224 patients, pharmacogenetic testing was performed for specific mutations of thiopurine S-methyltransferase (TPMT) in 93 patients currently or formerly being treated with AZA (especially young women with diagnoses of SLE or specific vasculitides).